GlassScriptPhysician profile
Ashish Kulhari
NPI 1194080127
$5,697.20
in general payments reported to CMS, 2019-2025
27 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,417 · 2020: $142 · 2021: $579 · 2022: $155 · 2023: $160 · 2024: $106 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $4,401.83 | 2019 | |
| Ucb, INC. | $138.67 | 2021-2023 | Briviact |
| Microvention, INC. | $131.34 | 2021 | |
| Qapel Medical INC | $122.22 | 2025 | |
| Abbvie INC. | $113.05 | 2020-2022 | |
| Stryker Corporation | $94.64 | 2023-2025 | Trevo, Broadway 8 |
| Eisai INC. | $69.22 | 2020-2021 | |
| Biogen, INC. | $64.16 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $61.81 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $58.58 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $46.84 | 2021 | |
| Kyowa Kirin, INC. | $44.39 | 2021 | |
| Lilly USA, LLC | $43.09 | 2023-2024 | Reyvow, Emgality |
| Microtransponder, INC. | $41.92 | 2024 | |
| Janssen Pharmaceuticals, INC | $35.06 | 2020-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $33.14 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $24.32 | 2023 | Keveyis |
| Medtronic, INC. | $23.04 | 2021 | |
| Depuy Synthes Sales INC. | $22.70 | 2024 | Emboguard |
| Emd Serono, INC. | $20.99 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $18.48 | 2021 | |
| Alnylam Pharmaceuticals INC. | $16.02 | 2024 | Amvuttra |
| Banner Life Sciences, LLC | $15.73 | 2022 | |
| Medtronic Vascular, INC. | $15.66 | 2019 | |
| Boston Scientific Corporation | $14.79 | 2021 | |
| Cardinal Health 200 LLC | $12.79 | 2020 | |
| Mallinckrodt Hospital Products INC. | $12.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Kulhari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.